9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesotheliomas

Estimated Enrollment: 50

Gender: All

Min Age: 39 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: to correlate the results of the vascularity marker of pleural mesothelioma CD74 of patients attended to Ain Shams University hospitals with the result response of treatment by chemotherapy ,overall survival and progreeion free survival,  assessment of vascular enothelial growth factor (VEGF) in patient with malignant pleural mesothelioma who attended to Ain Shams University and made comparison with the result of CD 74,  ,

Interventions: marker CD74 and vascular endothelial growth factor VEGF,

Phase:

Study Type: Observational

Study Design: Observational Model: Cohort, Time Perspective: Retrospective, ,

Primary Completion Date: May 2016

Completion Date: May 2016

Last  Posted Date: June 1, 2016

Location: Ain Shams University Hospital, Cairo, Egypt

Website Link: https://ClinicalTrials.gov/show/NCT02603315

Was this article helpful?
Dislike 0